Sale!

Culture Mycobacterium Atypical Non Tuberculous Mycobacterium NTM Test

Original price was: ₦ 65,000.Current price is: ₦ 58,500.

-10%

The Culture Mycobacterium Atypical Non Tuberculous Mycobacterium NTM Test is crucial for diagnosing infections caused by atypical mycobacteria. This test identifies non-tuberculous mycobacteria (NTM) which can lead to serious health issues. The test is priced at 65,000 NGN, with a discounted price of 58,500 NGN. It is essential for individuals showing symptoms of respiratory infections or those with weakened immune systems.

Book your test online and get free home sample collection

  • 100% Accurate Test Results
  • Get Tested at Nigeria No1 Genetic DNA Lab
  • Customer support Call 08077798758
Guaranteed Safe Checkout

Culture Mycobacterium Atypical Non Tuberculous Mycobacterium NTM Test

Introduction

The Culture Mycobacterium Atypical Non Tuberculous Mycobacterium NTM Test is a vital diagnostic tool used to identify infections caused by non-tuberculous mycobacteria (NTM). These organisms can lead to a range of health issues, particularly in individuals with compromised immune systems. Early detection through this test allows for timely intervention and treatment, significantly improving patient outcomes.

What the Test Measures

This test specifically measures the presence of atypical mycobacteria, which are distinct from the more commonly known Mycobacterium tuberculosis. It helps in identifying various species of NTM that may be responsible for infections.

Who Should Consider This Test?

Individuals experiencing symptoms such as persistent cough, fever, weight loss, or those with a history of lung disease or weakened immune systems should consider this test. Additionally, patients with unexplained respiratory issues or those who have been in contact with individuals diagnosed with NTM infections may benefit from testing.

Benefits of Taking the Test

  • Early detection of NTM infections can lead to prompt treatment.
  • Helps in differentiating between tuberculosis and non-tuberculous mycobacterial infections.
  • Provides critical information for managing respiratory diseases.
  • Assists healthcare providers in tailoring appropriate therapeutic strategies.

Understanding Your Results

Results from the Culture Mycobacterium Atypical NTM Test will indicate whether atypical mycobacteria are present in the sample. Positive results require further evaluation and may lead to additional testing to determine the specific type of mycobacteria involved. Negative results can provide reassurance, but further investigation may be warranted based on clinical symptoms.

Test Name and Price

Test Name Discount Price (NGN) Regular Price (NGN)
Culture Mycobacterium Atypical Non Tuberculous Mycobacterium NTM Test 58,500 NGN 65,000 NGN

How to Book the Test

To book your Culture Mycobacterium Atypical Non Tuberculous Mycobacterium NTM Test, please call or WhatsApp us at +2348077798758. Our team is ready to assist you with scheduling your appointment and answering any questions you may have.

Turnaround Time

Samples are accepted daily until 3:30 PM. The reporting schedule is as follows:

  • 1st Interim Report: 1 week
  • 2nd Interim Report: 3 weeks
  • 3rd Interim Report: 6 weeks
  • Final Report: 10 weeks
  • All positive cultures will be reported as soon as they are identified.

Sample Type

Various sample types can be submitted for this test, including:

  • Blood/Bone Marrow: 8 mL (5 mL min.) in Myco F / Lytic bottle.
  • CSF: 2 mL (1 mL min.) in a Red Top (No Additive) tube.
  • Pus/Body Fluids: Minimum 1 mL in a sterile container.
  • Endometrial Curettings/Tissue: In sterile normal saline.
  • Swabs: 1 mL in sterile normal saline.
  • Sputum/Urine: 2 Spot morning samples, 5-10 mL (1 mL min.) sputum or 10 mL (5 mL min.) urine.
  • Gastric Lavage: 5-10 mL (2 mL min.) in a sterile container.

Pre-Test Instructions

No special preparation is required prior to taking this test.

This test is essential for patients under the care of physicians, gynecologists, chest physicians, and neurologists, ensuring comprehensive care for those at risk of atypical mycobacterial infections.